(0.41%) 5 175.75 points
(0.37%) 38 976 points
(0.32%) 18 059 points
(0.81%) $78.74
(2.24%) $2.19
(0.68%) $2 324.30
(2.32%) $27.31
(0.74%) $972.40
(-0.17%) $0.927
(-0.55%) $10.81
(-0.33%) $0.794
(-0.33%) $91.15
Live Chart Being Loaded With Signals
Indoco Remedies Limited manufactures and sells formulations and active pharmaceutical ingredients in India and internationally. The company offers respiratory products, such as Karvol Plus, Febrex Plus, and Tuspel; stomatologicals products that include Sensodent-K, Sensoform Toothpaste, Sensoform Gum Paint, Rexidin M, Rexidin SRS, RR Sensoform Dental, Snowdent, Kidodent, Rexidin Plus, and Dentogel; gastrointestinal products, such as Carmicide, Cyclopam, Cyclomeff, and Nosic; pain/analgesics products that include Lignox and T-lac; and ophthal/otologicals products, such as Renolen, Homide, Dexoren S, Zincoren, Otorex, Mofloren-D, and Mofloren LP...
Stats | |
---|---|
今日成交量 | 403 807 |
平均成交量 | 100 189 |
市值 | 30.93B |
EPS | INR0 ( 2024-01-23 ) |
下一个收益日期 | ( INR2.80 ) 2024-05-21 |
Last Dividend | INR2.25 ( 2023-09-18 ) |
Next Dividend | INR0 ( N/A ) |
P/E | 30.48 |
ATR14 | INR0.403 (0.12%) |
音量 相关性
Indoco Remedies Limited 相关性
10 最正相关 | |
---|---|
ICICIGI.NS | 0.898 |
RADIOCITY.NS | 0.889 |
INSECTICID.NS | 0.883 |
INDUSTOWER.NS | 0.881 |
HDFCAMC.NS | 0.878 |
SAREGAMA.NS | 0.876 |
IDEA.NS | 0.874 |
PUNJABCHEM.NS | 0.869 |
SHOPERSTOP.NS | 0.866 |
TCIFINANCE.NS | 0.865 |
10 最负相关 | |
---|---|
SICAGEN.NS | -0.883 |
SMLT.NS | -0.881 |
OIL.NS | -0.875 |
STAMPEDE.NS | -0.873 |
STERTOOLS.NS | -0.871 |
NEWGEN.NS | -0.871 |
KEERTI.NS | -0.869 |
SURYAROSNI.NS | -0.863 |
ROTO.NS | -0.862 |
PDSMFL.NS | -0.856 |
你知道吗?
相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。
相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。
Indoco Remedies Limited 相关性 - 货币/商品
Indoco Remedies Limited 财务报表
Annual | 2022 |
营收: | INR16.40B |
毛利润: | INR11.19B (68.21 %) |
EPS: | INR15.44 |
FY | 2022 |
营收: | INR16.40B |
毛利润: | INR11.19B (68.21 %) |
EPS: | INR15.44 |
FY | 2022 |
营收: | INR15.04B |
毛利润: | INR10.40B (69.16 %) |
EPS: | INR16.80 |
FY | 2021 |
营收: | INR12.19B |
毛利润: | INR8.59B (70.49 %) |
EPS: | INR10.10 |
Financial Reports:
No articles found.
Indoco Remedies Limited Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
INR0.750 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR2.25 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | INR0.667 | 2005-09-15 |
Last Dividend | INR2.25 | 2023-09-18 |
Next Dividend | INR0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 21 | -- |
Total Paid Out | INR20.23 | -- |
Avg. Dividend % Per Year | 0.26% | -- |
Score | 1.79 | -- |
Div. Sustainability Score | 2.93 | |
Div.Growth Potential Score | 3.59 | |
Div. Directional Score | 3.26 | -- |
Year | Amount | Yield |
---|---|---|
2005 | INR0 | 0.00% |
2006 | INR0 | 0.00% |
2007 | INR0 | 0.00% |
2008 | INR0 | 0.00% |
2009 | INR0 | 0.00% |
2010 | INR0 | 0.00% |
2011 | INR0 | 0.00% |
2012 | INR0 | 0.00% |
2013 | INR0 | 0.00% |
2014 | INR0 | 0.00% |
2015 | INR0 | 0.00% |
2016 | INR0 | 0.00% |
2017 | INR0 | 0.00% |
2018 | INR1.000 | 0.52% |
2019 | INR0.300 | 0.14% |
2020 | INR0.300 | 0.16% |
2021 | INR1.500 | 0.49% |
2022 | INR0.750 | 0.17% |
2023 | INR2.25 | 0.55% |
2024 | INR0 | 0.00% |
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
POLYPLEX.NS | Dividend Knight | 2023-09-08 | Semi-Annually | 22 | 5.28% | |
JSWSTEEL.NS | Dividend Junior | 2023-07-11 | Annually | 20 | 1.70% | |
DOLLAR.NS | Dividend Junior | 2023-07-27 | Annually | 8 | 0.54% | |
AARVI.NS | Dividend Knight | 2023-09-15 | Annually | 7 | 1.38% | |
SPAL.NS | Dividend Junior | 2023-09-15 | Sporadic | 8 | 0.44% | |
MOTHERSON.NS | Dividend Junior | 2023-08-11 | Annually | 23 | 0.63% | |
HERITGFOOD.NS | Dividend Junior | 2023-08-14 | Annually | 23 | 0.44% | |
BIKAJI.NS | Dividend Junior | 2023-06-08 | Insufficient data to determine frequency | 2 | 0.06% | |
RANEHOLDIN.NS | Dividend Junior | 2023-07-27 | Annually | 21 | 0.95% | |
KOPRAN.NS | Dividend Junior | 2023-09-07 | Annually | 5 | 1.18% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0571 | 1.500 | 8.86 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0 | 1.200 | 0 | 0 | [0 - 0.3] |
returnOnEquityTTM | 0.0969 | 1.500 | -0.0350 | -0.0524 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 0 | 0.800 | -5.00 | -4.00 | [1 - 3] |
quickRatioTTM | 0 | 0.800 | -4.71 | -3.76 | [0.8 - 2.5] |
cashRatioTTM | 0 | 1.500 | -1.111 | -1.667 | [0.2 - 2] |
debtRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 0.6] |
interestCoverageTTM | 5.33 | 1.000 | 9.14 | 9.14 | [3 - 30] |
operatingCashFlowPerShareTTM | 14.32 | 2.00 | 5.23 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 14.32 | 2.00 | 2.84 | 5.68 | [0 - 20] |
debtEquityRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 2.5] |
grossProfitMarginTTM | 0.691 | 1.000 | 1.820 | 1.820 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.104 | 1.000 | 9.92 | 9.92 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0 | 1.000 | -1.111 | -1.111 | [0.2 - 2] |
assetTurnoverTTM | 0 | 0.800 | -3.33 | -2.67 | [0.5 - 2] |
Total Score | 2.93 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 30.22 | 1.000 | 7.05 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0969 | 2.50 | -0.0225 | -0.0524 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 14.32 | 2.00 | 5.23 | 5.68 | [0 - 30] |
dividendYielPercentageTTM | 0.675 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 14.32 | 2.00 | 5.23 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0.456 | 1.500 | -0.297 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0742 | 1.000 | -0.645 | 0 | [0.1 - 0.5] |
Total Score | 3.59 |
Indoco Remedies Limited
Indoco Remedies Limited manufactures and sells formulations and active pharmaceutical ingredients in India and internationally. The company offers respiratory products, such as Karvol Plus, Febrex Plus, and Tuspel; stomatologicals products that include Sensodent-K, Sensoform Toothpaste, Sensoform Gum Paint, Rexidin M, Rexidin SRS, RR Sensoform Dental, Snowdent, Kidodent, Rexidin Plus, and Dentogel; gastrointestinal products, such as Carmicide, Cyclopam, Cyclomeff, and Nosic; pain/analgesics products that include Lignox and T-lac; and ophthal/otologicals products, such as Renolen, Homide, Dexoren S, Zincoren, Otorex, Mofloren-D, and Mofloren LP. It also provides vitamins/minerals/nutrients that include Methycal, Cital UTI, SM Fibro, Cal Aid, SM Fibro, MCBM DHA, and Apispur; urology products, such as Carmicide and Cital; Cloben G and Scabex for dermatology; ATM for anti-infectives; Hemsyl for blood related; MCBM 69 and D Chiro for gynecological; and Spear for anti-haemorrhoidal. In addition, the company provides analytical services, such as impurity profile, particle size analysis, heavy metal analysis, polymorphism and compatibility studies, extractables and leachables studies, lyophilization studies, reference and working standards, forced degradation studies, and chromatographic method development and validation services. Further, it offers services that include architectural design, lighting, mechanical and utility engineering, project and construction management, electrical, control system, piping, structural design, data transfer system, and process engineering. The company serves general practitioners, pediatricians, consultant physicians, dentists, cardiologists, diabetologists, endocrinologists, gynaecologists, and ophthalmologists. The company was formerly known as Indo Continental Trading Company. Indoco Remedies Limited was founded in 1945 and is based in Mumbai, India.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。